Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA
Conditions: Cancer; Solid Tumor; Colorectal Cancer; Breast Cancer; Ovarian Cancer; Lung Cancer; Targeted Therapy; Chemotherapy; Immunotherapy; Precision Therapy Interventions: Genetic: SNP; Drug: Palbociclib 125mg; Drug: Bevacizumab Sponsors: Lebanese University; Haykel Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avastin | Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Colorectal Cancer | Genetics | Hospitals | Immunotherapy | Lebanon Health | Lung Cancer | Ovarian Cancer | Ovaries | Research